Research Article
[Retracted] Overexpression of 14-3-3δ Predicts Poor Prognosis in Extrahepatic Cholangiocarcinoma Patients
Table 1
Clinical and histopathological characteristics of 65 extrahepatic cholangiocarcinoma.
| No. of patients (%) | |
| Gender (%) | | Male | 37 (56.9) | Female | 28 (43.1) | Age (%) | | ≥65 years | 22 (33.8) | <65 years | 43 (66.2) | Tumour size (%) | | >2.5 cm | 35 (53.8) | ≤2.5 cm | 30 (46.2) | Pathologic differentiation (%) | | Well | 30 (46.2) | Moderate | 29 (44.6) | Poor | 6 (9.2) | Lymphatic permeation (%) | | No | 32 (49.2) | Yes | 33 (50.8) | Tumor stage (%) | | I+II | 25 (38.5) | III+IV | 40 (61.5) | 14-3-3δlevel (%) | | Negative | 12 (18.5) | Positive | 53 (81.5) |
|
|